Calidi Biotherapeutics, Inc. (AMEX:CLDI) Financings

Calidi Biotherapeutics, Inc.

Financings

RaiseDate
Registered direct offering of shares of common stock
Announced: about US$1.2M · US$1.17 a share
Use of proceeds: Working capital and general corporate purposes
Sep 17, 2026
Public offering of units of common stock or pre-funded warrants with common warrants
Announced: Ladenburg Thalmann & Co. Inc.
Dealers: Ladenburg Thalmann & Co. Inc. (lead)
Use of proceeds: Working capital and general corporate purposes
Mar 5, 2026
Public offering of common stock units and pre-funded warrant units
Closed: US$6.9M raised · US$2 a unit · Warrants at US$2 for 60 months · Ladenburg Thalmann & Co. Inc. +1
Dealers: Ladenburg Thalmann & Co. Inc. (lead), Laidlaw & Company (U.K.) Ltd.
Insiders: Management and board members participated
Aug 21, 2025
Warrant exercise of warrant inducement offering
Closed: US$4.6M raised · US$0.7 a share · ½ warrant at US$0.7 for 66 months · Ladenburg Thalmann & Co, Inc.
Dealers: Ladenburg Thalmann & Co, Inc. (lead)
Use of proceeds: Advance clinical and pre-clinical programs, continuing operating expenses and working capital
Aug 8, 2025

Read by 6ix AI from the company's releases